When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
AI for drug development: How trustworthy is the tech?
Pharma companies today deploy artificial intelligence with a potential to reduce the drug development cycle by half
Industries can harm health in many ways: Here are 3 that aren’t so obvious
Some products and practices are directly linked to avoidable ill health, planetary damage and social and health inequity, especially by …
As told to Parliament (March 14, 2023): After Uzbekistan cough syrup deaths, Centre cautioned pharma units
All that was discussed in the House through the day
Why Americans pay more for prescription drugs than anywhere else globally
The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high
It is critical to view antimicrobial resistance through a multi-dimensional lens
Reducing pollution from the pharmaceutical, agricultural and healthcare sectors is needed to reduce the emergence, transmission and spread of …
After cough-syrup, now eye drops: India-made solution causes 1 death, several infections in US
This could be particularly damning for India’s drug regulatory system since it is coming on the heels of cough-syrup-associated deaths in …
Budget 2023-24 live: Greening the economy is among top 7 priorities, says Nirmala Sitharaman in budget speech
Live updates from the budget speech February 1, 2023
Pharma’s dirty deals to stall generics
As generic companies, including Indian firms, collude with innovator pharma giants in pay-for-delay pacts, consumers pay a high price
Antibiotic residues in wastewater may trigger antimicrobial resistance in India, China: Study
Antimicrobial resistance results in an increase in morbidity, mortality and healthcare costs for the individual, health system and country
Antimicrobial resistance: Here is how pharma companies can reduce antibiotic pollution in effluents
There is a high risk of antibiotic residues entering the environment from wastewater used in manufacturing pharmaceuticals
2022 Chemistry Nobel awarded for ‘click chemistry’, which has possible applications in healthcare
Carolyn Bertozzi, Morten Meldal and Barry Sharpless worked on click chemistry, or linking chemicals together, and biorthogonal reactions, …
National List of Essential Medicines: 34 drugs enlisted in update after 7 years
The latest National List of Essential Medicines features 384 medicines, drops 26 old ones
How dosage of fever drugs has again highlighted nexus of pharma firms, doctors
No regulation on marketing strategies by drug companies has created a medical autocracy, the Dolo-650 controversy shows
D Srinivasa Reddy takes over as Director CSIR-IICT
Reddy will also hold the additional charge of the post of director of CSIR-IIIM, Jammu and director, CSIR-CDRI, Lucknow
When Big Pharma has all the answers
IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to these handful of companies; and all …
COVID-19 vaccines for all: Will Sputnik V speed up vaccination in India
Sputnik V’s entry may not dent the ongoing vaccine shortage in India, but its domestic production could change things by year-end
Single nanoparticle twists pave the way for medicines on demand: Study
Understanding chirality — twists within nanoparticles — can help several industries, including pharma
Remdisivir shows no benefits on COVID-19 patients in first clinical trial
Lancet paper contradicts Gilead results on drug which claimed improvement in patients
Beware of a deal with Trump
As the US president comes visiting to India there is worry about the demands he will make on intellectual property
Indian pharma firms receive 34% of FDA warnings this year
These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices
There's an unhealthy alliance between doctors and pharma firms
The government has shown little interest to penalise pharma companies that offer sops to doctors to push their drugs
US sound and fury over drug prices
The US Senate is outraged by the rapacious pricing policy of drug firms but will it act to reform the system?
Software outsmarts drug research
Now, a programme can bypass patented drug pathways and create synthetically-produced medicines
This is how rich nations protect profits of multinational pharma firms
When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out
